Here are relevant reports on : ultrasound-market
-
Electrophysiology Market by Product (Lab Devices (3D Mapping, Recording, ICE, X-ray Systems), Ablation Catheters (Cryoablation, Radiofrequency, Laser, Microwave), Diagnostic Catheters (Conventional, Advanced, Ultrasound)), End Use-Global Forecast to 2030
The global electrophysiology market, valued at US$11.41 billion in 2024, stood at US$12.55 billion in 2025 and is projected to advance at a resilient CAGR of 11.6% from 2025 to 2030, culminating in a forecasted valuation of US$21.72 billion by the end of the period. The rise of the electrophysiology market can be attributed to several drivers: the increasing prevalence of cardiovascular diseases, including arrhythmias and atrial fibrillation; patients and healthcare providers are increasingly favoring minimally invasive procedures over traditional surgical interventions; electrophysiological techniques, such as catheter ablation, offer less invasive options for treating certain cardiac arrhythmias; and government support and initiatives aimed at improving healthcare infrastructure and funding research and development in electrophysiology also contribute to market growth.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Ophthalmic Imaging Market by Product Type (Optical Coherence Tomography Systems, Ophthalmic Ultrasound Systems, Fundus Cameras), Application (Glaucoma, Retinopathies), End User (Hospitals, Ophthalmology Clinics, Optometry Clinics) - Global Forecast to 2030
The global ophthalmic imaging market, valued at US$2.7 billion in 2024, stood at US$2.8 billion in 2025 and is projected to advance at a resilient CAGR of 6.3% from 2025 to 2030, culminating in a forecasted valuation of US$3.8 billion by the end of the period. The ophthalmic imaging market is driven by the rising prevalence of eye diseases and an aging global population, which boosts demand for advanced diagnostic tools.
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
Non Invasive Prenatal Testing Market by Product (Consumables, Reagent, Ultrasound, NGS, PCR, Microarray), Services, Method (cfDNA, Biochemical Markers), Application (Aneuploidy, Microdeletion) & End-User (Hospital, Labs) - Global Forecasts to 2029
The global non invasive prenatal testing market, valued at US$6.4 billion in 2023, stood at US$7.2 billion in 2024 and is projected to advance at a resilient CAGR of 14.5% from 2024 to 2029, culminating in a forecasted valuation of US$14.1 billion by the end of the period. The primary growth factors propelling this market include spiking investments, incentives, and support from both state governments and private companies, which are driving access to and demand for NIPT technologies.
- Published: September 2024
- Price: $ 4950
- TOC Available:
-
US Medical Simulation Market by offering (Anatomical Models [Patient {High Fidelity}, Surgical {Laparoscopic, Ortho, Gynec, Spine}, Trainers, Ultrasound], Software), Technology (3D Printing, Virtual Patient, Procedural Rehearsal), End User - Forecast 2030
The US Medical Simulation market, valued at USD 1.20 billion in 2024, stood at USD 1.40 billion in 2025 and is projected to advance at a resilient CAGR of 15.2% from 2025 to 2030, culminating in a forecasted valuation of USD 2.83 billion by the end of the period. The US medical simulation market continues to expand, supported by rising demand for advanced clinical training, stricter regulatory and accreditation requirements, and a growing healthcare workforce.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Biopsy Devices Market by Product (Core needle biopsy (Automatic, Disposable), Technology (Ultrasound,stereotactic), Application (Oncology, Gastroenterology, Bone & Bone marrow biopsy), End User (Diagnostic imaging centres) - Global Forecast to 2030
The global biopsy devices market, valued at US$6.86B in 2023, is forecasted to grow at a 7.2% CAGR, reaching US$7.27B by 2024 and US$11.01B by 2030. The rising prevalence of cancer. Additionally the increasing preference for minimally invasive surgeries. Moreover, the improved reimbursement policies is likely to promote the growth of biopsy device market.
- Published: March 2025
- Price: $ 4950
- TOC Available:
-
Non-Thermal Processing Market for Food by Technology (HPP, PEF, Irradiation, Ultrasound, Cold Plasma), Food Type (Meat, Beverages), Function (Microbial Inactivation, Quality Assurance), and Region - Global Forecast to 2022
The global market for non-thermal processing market has grown exponentially in the last few years. The market is estimated to be valued at USD 818.6 Million in 2017, and is projected to reach USD 1,224.2 Million by 2022, at a CAGR of around 8.4% from 2017. Emerging economies such as India, China, and Brazil are the potential primary markets of the industry. Growing trend of novel technologies and process optimizaiton are driving the market for non-thermal processing. This report includes a study of business strategies, along with the product portfolios of leading companies. More than 160 developments were tracked for the 15 companies in the non-thermal processing market. It includes the profiles of leading companies such as Bosch (Germany), Bühler (Switzerland), Hiperbaric España (Spain), Nordion (Canada), Avure Technologies (US), Emerson (US), CHIC FresherTech (US), Elea Technology (Germany), Pulsemaster (Netherlands), Gray*Star (US), Dukane (US), and Symbios Technologies (US).
- Published: March 2018
- Price: $ 4950
- TOC Available:
-
Thrombectomy Devices Market by Type (Hydrodynamic, Ultrasound, Aspiration, Mechanical Thrombectomy), Application (Cardiovascular, Peripheral, Neurovascular), End User (Hospitals, Surgical Centers, Ambulatory, Academia, CROs)- Global Forecast to 2022
The global thrombectomy devices market is projected to grow at a CAGR of 6.7% . Some of the prominent players in the market are Medtronic plc (Ireland), Boston Scientific Corporation (U.S.), Johnson & Johnson (U.S.), Terumo Corporation (Japan), Penumbra, Inc. (U.S.), Spectranetics Corporation (U.S.), Edwards Lifesciences Corporation (U.S.), Argon Medical Devices, Inc. (U.S.), and Teleflex Incorporated (U.S.), were few other key players operating in the market.
- Published: April 2017
- Price: $ 4950
- TOC Available:
-
Neurodiagnostics Market by Product (Diagnostic & Imaging Systems (MRI, Ultrasound), Clinical Testing (PCR, NGS), Reagents & Consumables), Disease Pathology (Epilepsy, Stroke), End User and Region - Global Forecasts to 2024
The neurodiagnostics market is projected to reach USD 8.4 billion by 2024, at a CAGR of 7.3%. Some of the prominent players in this market includes GE Healthcare (US), Siemens Healthineers (Germany), Philips Healthcare (Netherlands), Hitachi, Ltd. (Japan), Canon, Inc. (Japan), Lifelines Neuro Company, LLC (US), Natus Medical Incorporated (US), Hoffman-La Roche AG (Switzerland), FUJIFILM Holdings Corporation (Japan), Mitsar Co., Ltd. (Russia), Advanced Brain Monitoring (US), Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories (US), QIAGEN N.V. (Netherlands), Nihon Kohden Corporation (Japan), ANT Neuro (Netherlands), Fonar Corporation (US), Fujirebio (Japan), DRG Instruments GmbH (Germany), Tecan Trading AG (Switzerland), Motion Lab Systems, Inc. (US), Rigaku Corporation (Japan), Neusoft Medical Systems Co., Ltd. (US), ELMIKO MEDICAL Sp. Z o.o. (Poland) and Ridge Diagnostics (US).
- Published: December 2019
- Price: $ 4950
- TOC Available:
-
Blood Flow Measurement Devices Market by Product (Ultrasound (Transit Time Flow Meter), Laser Doppler), Application (Invasive (CABG, Microvascular Surgery), Non-invasive (Cardiovascular, Gastroenterology & Tumor Monitoring)) - Global Forecast to 2021
The blood flow measurement devices market is projected to grow at a CAGR of 9.2%. The growth of the overall blood flow measurement devices market can be contributed to the growing prevalence of cardiovascular diseases and diabetes coupled with rising geriatric population, technological advancements, and the influx of VC funding.
- Published: March 2017
- Price: $ 4950
- TOC Available:
-
Ultrasound Needle Guides Market by Type (Reusable, Disposable), Application (Tissue Biopsy, Fluid Aspiration, Nerve Block, Regional Anesthesia, Vascular Access), End User (Hospitals, Clinics, ASC, Diagnostic Imaging Centers) & Region - Global Forecasts to 2027
The global ultrasound needle guides market, stood at US$274 million in 2022 and is projected to advance at a resilient CAGR of 6.1% from 2022 to 2028, culminating in a forecasted valuation of US$369 billion by the end of the period. Ultrasound needle guides have applications in the diagnosis and treatment of diseases such as cancer and CVD. The prevalence of these target diseases is increasing across the globe due to factors such as the rising geriatric population and the increasing adoption of sedentary lifestyles.
- Published: February 2023
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
